709 related articles for article (PubMed ID: 1281489)
21. Lineage commitment of CD34+ human hematopoietic progenitor cells.
Tjønnfjord GE; Steen R; Veiby OP; Egeland T
Exp Hematol; 1996 Jul; 24(8):875-82. PubMed ID: 8690045
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Kawakami Z; Ninomiya H; Tomiyama J; Abe T
Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
[TBL] [Abstract][Full Text] [Related]
23. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry.
Terstappen LW; Buescher S; Nguyen M; Reading C
Leukemia; 1992 Oct; 6(10):1001-10. PubMed ID: 1405753
[TBL] [Abstract][Full Text] [Related]
24. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
25. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
[TBL] [Abstract][Full Text] [Related]
26. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.
Alfinito F; Del Vecchio L; Rocco S; Boccuni P; Musto P; Rotoli B
Leukemia; 1996 Aug; 10(8):1326-30. PubMed ID: 8709638
[TBL] [Abstract][Full Text] [Related]
27. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia.
Nakakuma H; Nagakura S; Iwamoto N; Kawaguchi T; Hidaka M; Horikawa K; Kagimoto T; Shido T; Takatsuki K
Blood; 1995 Mar; 85(5):1371-6. PubMed ID: 7532041
[TBL] [Abstract][Full Text] [Related]
28. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis.
Jones J; Laffafian I; Cooper AM; Williams BD; Morgan BP
Br J Rheumatol; 1994 Aug; 33(8):707-12. PubMed ID: 8055195
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
[TBL] [Abstract][Full Text] [Related]
30. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis.
Shah VO; Civin CI; Loken MR
J Immunol; 1988 Mar; 140(6):1861-7. PubMed ID: 2964486
[TBL] [Abstract][Full Text] [Related]
33. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
Kinoshita T; Medof ME; Silber R; Nussenzweig V
J Exp Med; 1985 Jul; 162(1):75-92. PubMed ID: 2409211
[TBL] [Abstract][Full Text] [Related]
34. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor.
Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T
Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930
[TBL] [Abstract][Full Text] [Related]
35. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
36. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D
Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282
[TBL] [Abstract][Full Text] [Related]
37. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans.
Kansas GS; Muirhead MJ; Dailey MO
Blood; 1990 Dec; 76(12):2483-92. PubMed ID: 1702327
[TBL] [Abstract][Full Text] [Related]
38. Analysis of PI (phosphatidylinositol)-anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement-regulatory factor.
Taguchi R; Funahashi Y; Ikezawa H; Nakashima I
FEBS Lett; 1990 Feb; 261(1):142-6. PubMed ID: 1689670
[TBL] [Abstract][Full Text] [Related]
39. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
[TBL] [Abstract][Full Text] [Related]
40. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
